skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Does titration of mitomycin C as an adjunct to trabeculectomy significantly influence the intraocular pressure outcome?

Original Research

(2920) Views  (533) Full article downloads

Authors: Susan J Lee, Augusto Paranhos, M Bruce Shields

Published Date September 2008 Volume 2009:3 Pages 81 - 87
DOI: http://dx.doi.org/10.2147/OPTH.S3899

Susan J Lee1, Augusto Paranhos2, M Bruce Shields1

1Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut, USA; 2Federal University of São Paulo, São Paulo, Brazil

Purpose: To evaluate the benefit of titrating the concentration and exposure time of mitomycin C (MMC) as an adjunct to trabeculectomy.

Methods: This report consists of a retrospective study and a review of the literature. In the study, consecutive glaucoma patients were evaluated who underwent trabeculectomy with adjunctive MMC that was titrated for concentration and exposure time, based on patient’s risk factors for surgical failure. After minimum follow-up of 6 months, patients were divided into success (intraocular pressure 7–17 mmHg), hypertension (>17 mmHg) and hypotony (<7 mmHg) groups, which were compared with regard to MMC protocol and patient variables. The literature review included reports of trabeculectomy and adjunctive MMC with and without titration.

Results: One hundred and fifty-five eyes of 155 patients were studied. There were no significant differences between the three outcome groups and MMC protocol (p > 0.05). The only significant patient variable was older age in the hypotony group (p = 0.009). The literature is conflicting regarding the value of titrating MMC as an adjunct in trabeculectomy.

Conclusion: The outcome of trabeculectomy with adjunctive MMC appears to represent a complex interaction of patient and surgical variables. While there is some support for a benefit of titrating MMC according to individual patient variables, there is inadequate evidence at the present time to claim superiority for any MMC protocol, with or without titration.

Keywords: glaucoma surgery, trabeculectomy, mitomycin C, intraocular pressure








Readers of this article also read:

Comparing techniques for pterygium surgery
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Corneal lamellar grafting to repair late complications of mitomycin C trabeculectomy
Five-year extension of a clinical trial comparing the EX-PRESS glaucoma filtration device and trabeculectomy in primary open-angle glaucoma
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Multiple pregnancies and its relationship with the development of retinopathy of prematurity (ROP)